287 related articles for article (PubMed ID: 29728779)
1. Prevalence of selected pharmaceuticals in surface water receiving untreated sewage in northwest Pakistan.
Khan A; Shams DF; Khan W; Ijaz A; Qasim M; Saad M; Hafeez A; Baig SA; Ahmed N
Environ Monit Assess; 2018 May; 190(6):324. PubMed ID: 29728779
[TBL] [Abstract][Full Text] [Related]
2. Occurrence, distribution, and ecotoxicological risk assessment of selected pharmaceutical compounds in water from Lake Victoria, Uganda.
Nantaba F; Wasswa J; Kylin H; Palm WU; Bouwman H; Kümmerer K
Chemosphere; 2020 Jan; 239():124642. PubMed ID: 31521936
[TBL] [Abstract][Full Text] [Related]
3. Occurrence and a screening-level risk assessment of human pharmaceuticals in the Pearl River system, South China.
Zhao JL; Ying GG; Liu YS; Chen F; Yang JF; Wang L; Yang XB; Stauber JL; Warne MS
Environ Toxicol Chem; 2010 Jun; 29(6):1377-84. PubMed ID: 20821582
[TBL] [Abstract][Full Text] [Related]
4. Occurrence of selected pharmaceuticals in the principal sewage treatment plants in Rome (Italy) and in the receiving surface waters.
Patrolecco L; Capri S; Ademollo N
Environ Sci Pollut Res Int; 2015 Apr; 22(8):5864-76. PubMed ID: 25352396
[TBL] [Abstract][Full Text] [Related]
5. Occurrence of non-steroidal anti-inflammatory drugs in Tehran source water, municipal and hospital wastewaters, and their ecotoxicological risk assessment.
Eslami A; Amini MM; Yazdanbakhsh AR; Rastkari N; Mohseni-Bandpei A; Nasseri S; Piroti E; Asadi A
Environ Monit Assess; 2015 Dec; 187(12):734. PubMed ID: 26553436
[TBL] [Abstract][Full Text] [Related]
6. Ecological risk assessment of pharmaceuticals in the receiving environment of pharmaceutical wastewater in Pakistan.
Ashfaq M; Nawaz Khan K; Saif Ur Rehman M; Mustafa G; Faizan Nazar M; Sun Q; Iqbal J; Mulla SI; Yu CP
Ecotoxicol Environ Saf; 2017 Feb; 136():31-39. PubMed ID: 27810578
[TBL] [Abstract][Full Text] [Related]
7. Non-steroidal anti-inflammatory drugs in Indian rivers.
Shanmugam G; Sampath S; Selvaraj KK; Larsson DG; Ramaswamy BR
Environ Sci Pollut Res Int; 2014 Jan; 21(2):921-31. PubMed ID: 23832803
[TBL] [Abstract][Full Text] [Related]
8. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden.
Bendz D; Paxéus NA; Ginn TR; Loge FJ
J Hazard Mater; 2005 Jul; 122(3):195-204. PubMed ID: 15967274
[TBL] [Abstract][Full Text] [Related]
9. Pharmaceuticals and environmental risk assessment in municipal wastewater treatment plants and rivers from Peru.
Nieto-Juárez JI; Torres-Palma RA; Botero-Coy AM; Hernández F
Environ Int; 2021 Oct; 155():106674. PubMed ID: 34174591
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of endocrine disrupters and selected pharmaceuticals in Aisonas River (Greece) and environmental risk assessment using hazard indexes.
Stasinakis AS; Mermigka S; Samaras VG; Farmaki E; Thomaidis NS
Environ Sci Pollut Res Int; 2012 Jun; 19(5):1574-83. PubMed ID: 22116734
[TBL] [Abstract][Full Text] [Related]
11. Occurrence of naproxen, ibuprofen, and diclofenac residues in wastewater and river water of KwaZulu-Natal Province in South Africa.
Madikizela LM; Chimuka L
Environ Monit Assess; 2017 Jul; 189(7):348. PubMed ID: 28639109
[TBL] [Abstract][Full Text] [Related]
12. Study of pharmaceuticals in surface and wastewater from Cuernavaca, Morelos, Mexico: Occurrence and environmental risk assessment.
Rivera-Jaimes JA; Postigo C; Melgoza-Alemán RM; Aceña J; Barceló D; López de Alda M
Sci Total Environ; 2018 Feb; 613-614():1263-1274. PubMed ID: 28962074
[TBL] [Abstract][Full Text] [Related]
13. Acidic pharmaceuticals in domestic wastewater and receiving water from hyper-urbanization city of China (Shanghai): environmental release and ecological risk.
Duan YP; Meng XZ; Wen ZH; Chen L
Environ Sci Pollut Res Int; 2013 Jan; 20(1):108-16. PubMed ID: 22669562
[TBL] [Abstract][Full Text] [Related]
14. Wastewater treatment plants as a pathway for aquatic contamination by pharmaceuticals in the ebro river basin (northeast Spain).
Gros M; Petrović M; Barceló D
Environ Toxicol Chem; 2007 Aug; 26(8):1553-62. PubMed ID: 17702326
[TBL] [Abstract][Full Text] [Related]
15. Multi-phase partitioning, ecological risk and fate of acidic pharmaceuticals in a wastewater receiving river: the role of colloids.
Duan YP; Meng XZ; Wen ZH; Ke RH; Chen L
Sci Total Environ; 2013 Mar; 447():267-73. PubMed ID: 23391893
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceuticals and iodinated contrast media in a hospital wastewater: A case study to analyse their presence and characterise their environmental risk and hazard.
Mendoza A; Aceña J; Pérez S; López de Alda M; Barceló D; Gil A; Valcárcel Y
Environ Res; 2015 Jul; 140():225-41. PubMed ID: 25880605
[TBL] [Abstract][Full Text] [Related]
17. [Occurrence and risk assessment of five selected PPCPs in municipal wastewater treatment plant and the receiving water].
Wen ZH; Duan YP; Meng XZ; Chen L
Huan Jing Ke Xue; 2013 Mar; 34(3):927-32. PubMed ID: 23745396
[TBL] [Abstract][Full Text] [Related]
18. Spatial distribution of pharmaceuticals in conventional wastewater treatment plant with Sludge Treatment Reed Beds technology.
Kołecka K; Gajewska M; Stepnowski P; Caban M
Sci Total Environ; 2019 Jan; 647():149-157. PubMed ID: 30077845
[TBL] [Abstract][Full Text] [Related]
19. Suitability of passive sampling for the monitoring of pharmaceuticals in Finnish surface waters.
Lindholm-Lehto PC; Ahkola HS; Knuutinen JS; Koistinen J; Lahti K; Vahtera H; Herve SH
Environ Sci Pollut Res Int; 2016 Sep; 23(18):18043-54. PubMed ID: 27255325
[TBL] [Abstract][Full Text] [Related]
20. Monitoring the concentrations of nonsteroidal anti-inflammatory drugs and cyclooxygenase-inhibiting activities in the surface waters of the Tone Canal and Edo River Basin.
Nishi I; Kawakami T; Onodera S
J Environ Sci Health A Tox Hazard Subst Environ Eng; 2015; 50(11):1108-15. PubMed ID: 26191985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
